from merely three individuals—not a proven cure. Yet for a malignancy long defined by grim prognoses and limited options, this small trial offers something remarkable.
It provides a first, undeniable glimpse that even glioblastoma, a seemingly invincible foe, may finally have revealed a vulnerability. The path ahead remains long, but hope now has a continue reading …